FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery

GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Provides Improved Outcomes in Real-World Peripheral Arterial Disease Cases

Jan 30, 2017

W. L. Gore & Associates Receives Innovative Technology Designation from Vizient, Inc. for GORE® SYNECOR Biomaterial

Designation recognizes products that bring improvements to the healthcare industry

Dec 15, 2016

Gore Joins Vascular and Endovascular Leaders in Recognizing the 2016 Pioneers in Performance for North America

Leading Practitioners and Researchers from North America Commended for Commitment to Advancing Vascular and Endovascular Therapy

Nov 16, 2016

Gore Global Registry for Endovascular Aortic Treatment Completes Enrollment

Over 5,000 patients from 114 worldwide sites provide a unique perspective of real-world conditions

Nov 15, 2016

New Technology Add-On Payment Awarded for GORE® EXCLUDER® Iliac Branch Endoprosthesis

Recognition of new technology status will provide additional hospital reimbursement for IBE when used in FDA approved indications

Sep 27, 2016

One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN® Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease

New clinical study shows excellent patency consistent with previous study results of self-expanding stent-graft in long, complex SFA lesions

Sep 20, 2016

First Implant Completed in Pivotal Study of GORE® TAG® Thoracic Branch Endoprosthesis

Enrollment begins on new clinical study for the first device designed specifically for the endovascular treatment of aortic arch lesions

Sep 19, 2016

GORE® VIABAHN® Endoprosthesis Marks 20 Years of Proven Performance

Market-leading stent-graft has evolved to address range of indications, patient needs

Sep 07, 2016

GORE® DrySeal Flex Introducer Sheath Advances Care through Access

New sheath provides exceptional access to challenging anatomies and branch vessels

Aug 30, 2016